共 50 条
- [34] ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (06): : 610 - 620
- [35] Current therapeutic strategies for diffuse large B-cell lymphoma INTERNIST, 2016, 57 (03): : 214 - +
- [38] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231